Alemnew Dagnew

Alemnew Dagnew has a diverse range of work experience in the medical research and development field. Their most recent position was as a Clinical Development Leader at the Bill & Melinda Gates Medical Research Institute, starting in August 2020. Prior to that, they worked at GSK Vaccines for five years as a Clinical Development Physician from March 2015 to August 2020. Alemnew also had experience at Novartis Vaccines, where they held the role of Clinical Development Physician from March 2014 to March 2015, and from July 2011 to February 2014. Alemnew Dagnew began their career in 2005 as a Lecturer at Mekelle University in Ethiopia before transitioning to the Armauer Hansen Research Institute (AHRI) as a Student from September 2006 to May 2009. Alemnew then pursued a Masters in Vaccinology and Pharmaceutical Clinical Development from May 2009 to April 2011 at Novartis Vaccines and Diagnostics in Siena, Italy.

Alemnew Dagnew has a diverse education history. In 1996, they began studying at Addis Ababa University, where they pursued an MD degree for an unspecified period of time, completing it in 2004. Later, from 2009 to 2011, Alemnew attended Università degli Studi di Siena, obtaining a Master's degree in Vaccinology and Pharmaceutical Clinical Development. Additionally, they pursued further studies at Addis Ababa University, specializing in Medical Microbiology, although the specific dates for this degree are unclear.

In terms of certifications, Alemnew Dagnew obtained the "Verified International Academic Qualifications" certification from the World Education Services in May 2021.